Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

MedWellAI (MWAI) EBIT (2016 - 2025)

MedWellAI (MWAI) has disclosed EBIT for 11 consecutive years, with -$273988.0 as the latest value for Q4 2025.

  • Quarterly EBIT rose 13.05% to -$273988.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $496298.0 through Dec 2025, up 185.23% year-over-year, with the annual reading at -$793644.0 for FY2025, 91.25% up from the prior year.
  • EBIT for Q4 2025 was -$273988.0 at MedWellAI, up from -$326034.0 in the prior quarter.
  • The five-year high for EBIT was $11.9 million in Q2 2021, with the low at -$16.3 million in Q1 2021.
  • Average EBIT over 5 years is -$963036.7, with a median of -$333772.0 recorded in 2021.
  • The sharpest move saw EBIT tumbled 4747.28% in 2021, then soared 157693.04% in 2025.
  • Over 5 years, EBIT stood at -$331865.0 in 2021, then plummeted by 84.01% to -$610649.0 in 2022, then skyrocketed by 45.03% to -$335679.0 in 2023, then increased by 6.13% to -$315096.0 in 2024, then grew by 13.05% to -$273988.0 in 2025.
  • According to Business Quant data, EBIT over the past three periods came in at -$273988.0, -$326034.0, and $2.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.